Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities

Siemens Acquires Dotmatics for $5.1 Billion

July 1, 2025

Software

Siemens AG has completed the acquisition of Dotmatics, a Boston-based life sciences R&D software provider and portfolio company of Insight Partners, for an enterprise value of $5.1 billion. Dotmatics will join Siemens' Digital Industries Software business to expand the Siemens Xcelerator portfolio into Life Sciences, adding over $300 million in revenue and enabling AI-powered end-to-end scientific R&D workflows.

Insightful Science Acquires Dotmatics

March 22, 2021

Cloud & SaaS

Insightful Science, a PE-backed life sciences software company, has entered into a transaction to acquire Dotmatics, a cloud-first scientific R&D data management and informatics SaaS provider. The combined company will create an end-to-end, cloud-first scientific research platform aimed at improving lab efficiency and accelerating discovery across pharmaceuticals, biotechnology, chemicals and materials industries.

Dotmatics Acquires Virscidian

September 25, 2024

Software

Dotmatics has acquired Virscidian, a provider of analytical chemistry solutions and automated chromatography and mass spectrometry data processing, to enhance its laboratory informatics and analytics capabilities. The deal expands Dotmatics' Luma Scientific Intelligence Platform with Virscidian's Analytical Studio, strengthening support for high-throughput experimental design and small-molecule R&D workflows.

Dotmatics Acquires EasyPanel

July 30, 2024

Software

Dotmatics has acquired EasyPanel, a specialist provider of flow cytometry panel design software, to broaden its flow cytometry capabilities and integrate panel design into its existing offerings such as OMIQ and FCS Express. The acquisition gives Dotmatics an end-to-end capability for flow cytometry workflows and adds EasyPanel's intelligent, algorithm-driven panel design and inventory management tools to its scientific software platform.

Genome Medical Acquires GeneMatters

August 30, 2021

Healthcare Services

Genome Medical, a South San Francisco–based genomic care delivery company, will acquire GeneMatters, a telehealth genetic counseling and software solutions provider. The deal coincides with Genome Medical's closing of a $60 million Series C financing led by Casdin Capital to accelerate commercial growth and expand technology-enabled genetic services.

Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business

July 14, 2022

Biotechnology

Genetic Technologies Limited (GENE) completed the acquisition of the direct-to-consumer eCommerce business and distribution rights of AffinityDNA, including websites, brand identities, laboratory testing and distribution agreements. The deal expands GENE’s direct-to-consumer channel and product portfolio across the US, UK and Europe, adding AffinityDNA’s consumer and pet genomics offerings to GENE’s geneType and EasyDNA brands.